Mostrar el registro sencillo del ítem

dc.contributor.authorMunekata, P. E. S.
dc.contributor.authorPateiro, M.
dc.contributor.authorConte-Junior, C. A.
dc.contributor.authorDomínguez, R.
dc.contributor.authorNawaz, A.
dc.contributor.authorWalayat, N.
dc.contributor.authorMOVILLA FIERRO, ELENA 
dc.contributor.authorLorenzo, J. M.
dc.date.accessioned2024-01-02T10:03:38Z
dc.date.available2024-01-02T10:03:38Z
dc.date.issued2021
dc.identifier.issn1660-3397
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/34203532es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/18488
dc.description.abstractMarine alkaloids comprise a class of compounds with several nitrogenated structures that can be explored as potential natural bioactive compounds. The scientific interest in these compounds has been increasing in the last decades, and many studies have been published elucidating their chemical structure and biological effects in vitro. Following this trend, the number of in vivo studies reporting the health-related properties of marine alkaloids has been increasing and providing more information about the effects in complex organisms. Experiments with animals, especially mice and zebrafish, are revealing the potential health benefits against cancer development, cardiovascular diseases, seizures, Alzheimer's disease, mental health disorders, inflammatory diseases, osteoporosis, cystic fibrosis, oxidative stress, human parasites, and microbial infections in vivo. Although major efforts are still necessary to increase the knowledge, especially about the translation value of the information obtained from in vivo experiments to clinical trials, marine alkaloids are promising candidates for further experiments in drug development.
dc.language.isoen
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleMarine Alkaloids: Compounds with In Vivo Activity and Chemical Synthesis
dc.typeJournal Articlees
dc.authorsophosMunekata, P. E. S.;Pateiro, M.;Conte-Junior, C. A.;Domínguez, R.;Nawaz, A.;Walayat, N.;Movilla Fierro, E.;Lorenzo, J. M.
dc.identifier.doi10.3390/md19070374
dc.identifier.pmid34203532
dc.identifier.sophos43277
dc.issue.number7
dc.journal.titleMarine Drugs
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.)::Área Sanitaria de Ourense, Verín e O Barco de Valdeorras - Complexo Hospitalario Universitario de Ourense
dc.page.initial374
dc.relation.publisherversionhttps://mdpi-res.com/d_attachment/marinedrugs/marinedrugs-19-00374/article_deploy/marinedrugs-19-00374-v2.pdf?version=1625228958es
dc.rights.accessRightsopenAccess
dc.subject.keywordCHUOes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo de Revisiónes
dc.volume.number19


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional